| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Barabe Timothy C serves as a Director at HTFL and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 10 buys and 6 sells. Those positions are worth an estimated $3.6M at current prices.
Historically, Barabe Timothy C's trades have earned a below-average insider score of 49/100 across 5 rated trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -17.5%.
The biggest single holding is HTFL (~$3.6M) as Director.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 17, 2020 | RNAC Cartesian Therapeutics, Inc. | Director | Buy | 5,000 | $2.00 | $10,000.00 | +6.0% | |
| Aug 13, 2019 | RNAC Cartesian Therapeutics, Inc. | Director | Buy | 10,000 | $1.72 | $17,200.00 | +133.5% | |
| Jun 18, 2019 | VEEV Veeva Systems Inc | Director | Sell | 727 | $167.19 | $121,549.38 | -7.8% | |
| Nov 10, 2017 | RNAC Cartesian Therapeutics, Inc. | Director | Buy | 5,000 | $9.37 | $46,840.00 | +200.6% |